Anthony E. Maida Iii.

Director, Spectrum Pharmaceuticals.

Companies

Oncotelic Therapeutics, Inc.CHIEF CLINICAL OFFICER Jul 16, 2021 to now¹
Oncotelic Therapeutics, Inc.Board member May 21, 2020 to now²
9 METERS BIOPHARMA, INC.Board member Feb 8, 2018 to May 4, 2020³
Spectrum PharmaceuticalsBoard member Feb 22, 2007 to May 31, 2019⁴
RANGE IMPACT, INC.Board member Mar 23, 2012 to May 13, 2019⁵
ONCOSEC MEDICAL IncBoard member Jul 5, 2011 to Apr 3, 2017⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROncotelic Therapeutics, Inc., CHIEF CLINICAL OFFICER
2
SEC EDGAROncotelic Therapeutics, Inc., Board member
3
SEC EDGAR9 METERS BIOPHARMA, INC., Board member
4
SEC EDGARSpectrum Pharmaceuticals, Board member
5
SEC EDGARRANGE IMPACT, INC., Board member
6
SEC EDGARONCOSEC MEDICAL Inc, Board member